501LBA LBA Orals: Phase 1 Expansion Results of IDE397, a First-in-class, Oral, MAT2A Inhibitor (mat2ai) in MTAP Deleted(del) Non-Small Cell Lung Cancer (NSCLC) and Urothelial Cancer (UC)

B. Herzberg, M. Johnson,C.G. Kim,A. Tolcher,J. Rodon,C. Mantia, J. Liu, A. Tripathi, L. Paz-Ares Rodriguez, T. De La Motte Rouge,C.M. Choi,J.Y. Han, L. Kwei, E. Liu,J. Sachdev, M. O’Quigley, M. White,D. Beaupre,H.R. Kim

European Journal of Cancer（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined